HUTCHMED (China) Limited American Depositary Shares HCM
$14.05
+0.79%
at last close
Market Cap$2.44 billion
P/E Ratio—
Div Yield—
Volume22.4K
52-Week Range
$9.77$17.79
Analyst Ratings
- Consensus
- Moderate Buy — 1 Buy · 1 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $15.50 (+10.3% upside)
Key Stats
- Today's Range
- $14.05 – $14.28
- 50-Day Range
- $11.80 – $14.93
- 52-Week Range
- $9.77 – $17.79
- Volume
- 22K shs
- Average Volume
- 64K shs
- Market Cap
- $2.44 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.14%
- Days to Cover
- 2.63
About HUTCHMED (China) Limited American Depositary Shares
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Related Stocks
Compare head-to-head: HCM vs NVDA·HCM vs AAPL·HCM vs GOOGL·HCM vs MSFT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.